Mansi Shah, MD

Articles by Mansi Shah, MD

Why a Patient With Multiple Myeloma Might Decline Stem Cell Transplant: Mansi Shah, MD

ByHayden E. Klein,Laura Joszt, MA,Mansi Shah, MD

June 30th 2025

Financial, family, and logistical challenges often lead patients to choose ongoing therapies over stem cell transplantation, says Mansi Shah, MD.

How Transplant, CAR T, and Bispecifics Fit Into Myeloma Care: Mansi Shah, MD

ByHayden E. Klein,Laura Joszt, MA,Mansi Shah, MD

June 27th 2025

Mansi Shah, MD, explains how treatment sequencing and patient eligibility guide the use of these therapies in multiple myeloma.

Stem Cell Transplant Remains Cost-Effective Option for MM: Mansi Shah, MD

ByLaura Joszt, MA,Hayden E. Klein,Mansi Shah, MD

June 11th 2025

Mansi Shah, MD, discusses the role of stem cell transplant in multiple myeloma (MM) and the logistical barriers to wider adoption of bispecific therapies.

Mansi Shah, MD

Articles by Mansi Shah, MD

Why a Patient With Multiple Myeloma Might Decline Stem Cell Transplant: Mansi Shah, MD

How Transplant, CAR T, and Bispecifics Fit Into Myeloma Care: Mansi Shah, MD

Stem Cell Transplant Remains Cost-Effective Option for MM: Mansi Shah, MD

Latest Updated Articles

Trending on AJMC

Andes Hantavirus FAQs: What to Know as Quarantined Cruise Passengers Return Home

Rituximab Suppresses Clinical Relapses, MRI Activity in Pediatric MS

Cancer’s Hidden Wound: Trauma From Diagnosis Through Survivorship

New Therapies Offer Hope for Vitiligo, an Often Misunderstood and Undertreated Disease

CAR T Therapy Likely the Next Frontier for Treating Patients With MG: James F. Howard, MD